Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 275Carcinoma, Intraductal, Noninfiltrating 25Breast Carcinoma In Situ 21Breast Neoplasms, Male 12Neoplasm Metastasis 10Neoplasms 7Inflammatory Breast Neoplasms 7Breast Cancer Female 4Obesity 3Endometrial Neoplasms 3Carcinoma, Ductal, Breast 3Breast Diseases 3Sleep Wake Disorders 2Hot Flashes 2ER+ Breast Cancer 2Carcinoma, Lobular 2Vitamin D Deficiency 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Risk Reduction Behavior 1Recurrence 1Pulmonary Fibrosis 1Primary Breast Cancer 1Premenopausal Breast Cancer 1Precancerous Conditions 1Patient Acceptance of Health Care 1Paget's Disease, Mammary 1Ovarian Neoplasms 1

Interventions

Tamoxifen 1Goserelin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperlipidemias × Tamoxifen × Breast × Clear all
NCT00827307 2011-08-08

Zoladex Plus Tamoxifen in Breast Cancer

Zhejiang Cancer Hospital

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms, Hyperlipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡